Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2A | P08913 | 1/20 | 0.33 |
| ▸ | DRD5 | P21918 | 1/20 | 0.33 |
| ▸ | DRD3 | P35462 | 1/20 | 0.33 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.33 |
| ▸ | KCNQ4 | P56696 | 3/20 | 0.32 |
| ▸ | KCNQ5 | Q9NR82 | 3/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.31 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.31 |
| ▸ | RORC | P51449 | 2/20 | 0.30 |
| ▸ | EGFR | P00533 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7139709 | 0.88 | HDAC1 (0.36) | KCNQ4KCNQ5MEN1KMT2AL3MBTL1 | |
| SCHEMBL7145150 | 0.85 | ADRA2A (0.35) | ADRA2ADRD5DRD3P2RY6KCNQ4 | |
| SCHEMBL7145353 | 0.83 | HCAR3 (0.33) | ALDH1A1MAPTMEN1KMT2AL3MBTL1 | |
| SCHEMBL7704614 | 0.80 | HDAC2 (0.37) | MEN1KMT2AL3MBTL1 | |
| SCHEMBL7139782 | 0.79 | MEN1 (0.36) | ADRA2ADRD5DRD3P2RY6ALDH1A1 | |
| SCHEMBL7147995 | 0.78 | ALDH1A1 (0.36) | ADRA2ADRD5DRD3P2RY6ALDH1A1 | |
| SCHEMBL7142689 | 0.77 | KDM4D (0.33) | — | |
| SCHEMBL7139585 | 0.74 | MMP8 (0.35) | ALDH1A1MAPTL3MBTL1HCAR3RORC | |
| SCHEMBL7146684 | 0.74 | KCNQ4 (0.39) | ADRA2ADRD5DRD3P2RY6KCNQ4 | |
| SCHEMBL7142171 | 0.73 | P2RY6 (0.38) | ADRA2ADRD5DRD3P2RY6KCNQ4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1224174-B1 | BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS | HOFFMANN LA ROCHE (CH) | 2003-09-17 | — | — | EP | disclosed |
| EP-1224174-A2 | BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS | F. HOFFMANN-LA ROCHE AG (CH) | 2002-07-24 | — | — | EP | disclosed |
| US-6407094-B1 | 4-5-DIDEHYDRO-1,5-BENZODIAZEPIN-2-ONE DERIVATIVES; PSYCHOLOGICAL, NERVOUS SYSTEM, AND BRAIN DISORDERS; COGNITION ACTIVATORS; ALZHEIMER*S DISEASE, SCHIZOPHRENIA | HOFFMANN-LA ROCHE INC. | 2002-06-18 | — | — | US | disclosed |
| WO-2001029011-A2 | BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS | F. HOFFMANN-LA ROCHE AG (CH) | 2001-04-26 | — | — | WO | disclosed |